Cargando…

Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection

Objective: The purpose of this study was to develop and validate a nomogram model for the prediction of survival outcome in rectal cancer patients who underwent surgical resection. Methods: A total of 9,919 consecutive patients were retrospectively identified using the Surveillance, Epidemiology, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bochao, Wang, Jingchao, Ma, Zhicheng, Ye, Haikun, Yang, Tao, Meng, Kewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154568/
https://www.ncbi.nlm.nih.gov/pubmed/37151355
http://dx.doi.org/10.3389/pore.2023.1611014
_version_ 1785036152630149120
author Zhao, Bochao
Wang, Jingchao
Ma, Zhicheng
Ye, Haikun
Yang, Tao
Meng, Kewei
author_facet Zhao, Bochao
Wang, Jingchao
Ma, Zhicheng
Ye, Haikun
Yang, Tao
Meng, Kewei
author_sort Zhao, Bochao
collection PubMed
description Objective: The purpose of this study was to develop and validate a nomogram model for the prediction of survival outcome in rectal cancer patients who underwent surgical resection. Methods: A total of 9,919 consecutive patients were retrospectively identified using the Surveillance, Epidemiology, and End Results (SEER) database. Significant prognostic factors were determined by the univariate and multivariate Cox analysis. The nomogram model for the prediction of cancer-specific survival (CSS) in rectal cancer patients were developed based on these prognostic variables, and its predictive power was assessed by the concordance index (C-index). Calibration curves were plotted to evaluate the associations between predicted probabilities and actual observations. The internal and external cohort were used to further validate the predictive performance of the prognostic nomogram. Results: All patients from the SEER database were randomly split into a training cohort (n = 6,944) and an internal validation cohort (n = 2,975). The baseline characteristics of two cohorts was comparable. Independent prognostic factors were identified as age, pT stage, lymph node metastasis, serum CEA level, tumor size, differentiation type, perineural invasion, circumferential resection margin involvement and inadequate lymph node yield. In the training cohort, the C-index of the nomogram was 0.719 (95% CI: 0.696–0.742), which was significantly higher than that of the TNM staging system (C-index: 0.606, 95% CI: 0.583–0.629). The nomogram had a C-index of 0.726 (95% CI: 0.691–0.761) for the internal validation cohort, indicating a good predictive power. In addition, an independent cohort composed of 202 rectal cancer patients from our institution were enrolled as the external validation. Compared with the TNM staging system (C-index: 0.573, 95% CI: 0.492–0.654), the prognostic nomogram still showed a better predictive performance, with the C-index of 0.704 (95% CI: 0.626–0.782). Calibration plots showed a good consistency between predicted probability and the actual observation in the training and two validation cohorts. Conclusion: The nomogram showed an excellent predictive ability for survival outcome of rectal cancer patients, and it might provide an accurate prognostic stratification and help clinicians determine individualized treatment strategies.
format Online
Article
Text
id pubmed-10154568
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101545682023-05-04 Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection Zhao, Bochao Wang, Jingchao Ma, Zhicheng Ye, Haikun Yang, Tao Meng, Kewei Pathol Oncol Res Pathology and Oncology Archive Objective: The purpose of this study was to develop and validate a nomogram model for the prediction of survival outcome in rectal cancer patients who underwent surgical resection. Methods: A total of 9,919 consecutive patients were retrospectively identified using the Surveillance, Epidemiology, and End Results (SEER) database. Significant prognostic factors were determined by the univariate and multivariate Cox analysis. The nomogram model for the prediction of cancer-specific survival (CSS) in rectal cancer patients were developed based on these prognostic variables, and its predictive power was assessed by the concordance index (C-index). Calibration curves were plotted to evaluate the associations between predicted probabilities and actual observations. The internal and external cohort were used to further validate the predictive performance of the prognostic nomogram. Results: All patients from the SEER database were randomly split into a training cohort (n = 6,944) and an internal validation cohort (n = 2,975). The baseline characteristics of two cohorts was comparable. Independent prognostic factors were identified as age, pT stage, lymph node metastasis, serum CEA level, tumor size, differentiation type, perineural invasion, circumferential resection margin involvement and inadequate lymph node yield. In the training cohort, the C-index of the nomogram was 0.719 (95% CI: 0.696–0.742), which was significantly higher than that of the TNM staging system (C-index: 0.606, 95% CI: 0.583–0.629). The nomogram had a C-index of 0.726 (95% CI: 0.691–0.761) for the internal validation cohort, indicating a good predictive power. In addition, an independent cohort composed of 202 rectal cancer patients from our institution were enrolled as the external validation. Compared with the TNM staging system (C-index: 0.573, 95% CI: 0.492–0.654), the prognostic nomogram still showed a better predictive performance, with the C-index of 0.704 (95% CI: 0.626–0.782). Calibration plots showed a good consistency between predicted probability and the actual observation in the training and two validation cohorts. Conclusion: The nomogram showed an excellent predictive ability for survival outcome of rectal cancer patients, and it might provide an accurate prognostic stratification and help clinicians determine individualized treatment strategies. Frontiers Media S.A. 2023-04-19 /pmc/articles/PMC10154568/ /pubmed/37151355 http://dx.doi.org/10.3389/pore.2023.1611014 Text en Copyright © 2023 Zhao, Wang, Ma, Ye, Yang and Meng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pathology and Oncology Archive
Zhao, Bochao
Wang, Jingchao
Ma, Zhicheng
Ye, Haikun
Yang, Tao
Meng, Kewei
Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
title Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
title_full Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
title_fullStr Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
title_full_unstemmed Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
title_short Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
title_sort development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
topic Pathology and Oncology Archive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154568/
https://www.ncbi.nlm.nih.gov/pubmed/37151355
http://dx.doi.org/10.3389/pore.2023.1611014
work_keys_str_mv AT zhaobochao developmentandvalidationofaprognosticnomogramforrectalcancerpatientswhounderwentsurgicalresection
AT wangjingchao developmentandvalidationofaprognosticnomogramforrectalcancerpatientswhounderwentsurgicalresection
AT mazhicheng developmentandvalidationofaprognosticnomogramforrectalcancerpatientswhounderwentsurgicalresection
AT yehaikun developmentandvalidationofaprognosticnomogramforrectalcancerpatientswhounderwentsurgicalresection
AT yangtao developmentandvalidationofaprognosticnomogramforrectalcancerpatientswhounderwentsurgicalresection
AT mengkewei developmentandvalidationofaprognosticnomogramforrectalcancerpatientswhounderwentsurgicalresection